The $2.6 Billion Pill — Methodologic and Policy Considerations

Jerry Avorn

New England Journal of Medicine · 2015 · 324 citations · 1 references

Concepts

Abstract

Interview with Dr. Jerry Avorn on a new estimate of the cost of bringing a drug to market. (12:09)Download An industry-supported center claims that it costs companies $2.6 billion to develop a new drug. But we need a broader-based and more transparent reckoning of research-and-development costs to inform discussions about fostering innovation and paying for medications.

References

1